Macrophage accumulation participates decisively in the development and exacerbation of atherosclerosis. Circulating monocytes, the precursors of macrophages, display heterogeneity in mice and humans, but their relative contribution to atherogenesis remains unknown. We report here that the Ly-6C hi monocyte subset increased dramatically in hypercholesterolemic apoE-deficient mice consuming a high-fat diet, with the number of Ly-6C hi cells doubling in the blood every month. Ly-6C hi monocytes adhered to activated endothelium, infiltrated lesions, and became lesional macrophages. Hypercholesterolemia-associated monocytosis (HAM) developed from increased survival, continued cell proliferation, and impaired Ly-6C hi to Ly-6C lo conversion and subsided upon statin-induced cholesterol reduction. Conversely, the number of Ly-6C lo cells remained unaffected. Thus, we believe that Ly-6C hi monocytes represent a newly recognized component of the inflammatory response in experimental atherosclerosis. Nonstandard abbreviations used: AcLDL, acetylated low-density lipoprotein; CCR2, C-C motif chemokine receptor 2; CD62L, CD62 ligand; HAM, hypercholesterolemia-associated monocytosis; MHEC, mouse heart EC.
Introduction
During atherogenesis, an inflammatory process, leukocytes and lipids accumulate in the aortic intima (1, 2) . Lipid-rich macrophages, known as foam cells in atheromata, secrete inflammatory mediators that stimulate smooth muscle cell migration and proliferation and participate in plaque development and rupture as well as thrombosis. Serum C-reactive protein and other molecular mediators of inflammation have broadened our understanding of the disease by illustrating that peripheral blood can afford valuable prognostic information (3, 4) . Leukocyte counts rise in atherosclerotic patients. Yet, the extent to which circulating leukocyte subsets reflect the inflammatory response during atherogenesis remains less defined (5) (6) (7) (8) (9) . This study tested the hypothesis that leukocyte heterogeneity in atherosclerosis could provide novel markers of and mechanistic insights into atherogenesis.
Prevailing concepts view monocytes as intermediary cells that continuously develop in the bone marrow, circulate in the bloodstream, and migrate unselected into tissue, where they become macrophages, dendritic cells, or other tissue descendants (10) (11) (12) . Studies in atherosclerotic mice have shown that bone marrowderived circulating monocytes populate atherosclerotic lesions (13) (14) (15) (16) (17) , and many studies support an active role for monocytes/ macrophages in atherosclerosis (reviewed in refs. 1, 2) . The appreciation of monocyte heterogeneity (18) (19) (20) has led to the hypothesis that monocytes commit for specific functions while still in the circulation. Indeed, both human and mouse monocytes fall into at least 2 phenotypically distinct subsets: Ly-6C hi (which are also phenotypically Gr-1 + CCR2 + CX3CR1 lo ) and Ly-6C lo (which are also phenotypically Gr-1 -CCR2 -CX3CR1 hi ) mouse monocytes correspond to human CD14 hi CD16and CD14 + CD16 + monocytes, respectively (19, (21) (22) (23) (24) . Ly-6C hi cells selectively populate sites of experimentally induced inflammation, while their Ly-6C lo counterparts can enter lymphoid and nonlymphoid tissues under homeostatic conditions (24) .
This study explored Ly-6C hi and Ly-6C lo monocytes in atherosclerotic mice. The results show that hypercholesterolemia induced a surprisingly profound expansion of blood Ly-6C hi but not Ly-6C lo monocytes, a process we termed hypercholesterolemia-associated monocytosis (HAM). Our results also establish a direct link between circulating Ly-6C hi monocytes and lesional macrophages.
Results
Hypercholesterolemic apoE -/mice undergo gradual and systemic monocytosis of the Ly-6C hi subset. To test the hypothesis that high-fat feeding alters the repertoire of circulating monocytes, we analyzed peripheral blood mononuclear cells from C57BL/6 wild-type (referred to as apoE +/+ ) and apoE -/mice that consumed either regular chow or Western diet (high in cholesterol and fat) for 25 weeks. Monocytes were defined as CD11b hi CD90 lo B220 lo CD49b lo NK1.1 lo Ly-6G lo mononuclear cells by flow cytometry, as previously reported (16) , and further divided into Ly-6C hi and Ly-6C lo fractions ( Figure 1A) . apoE -/mice on Western diet had a 4-fold increase of total circulating monocytes when compared with the same mice on chow ( Figure 1B ). Monocytosis in apoE -/mice on Western diet resulted from a 14-fold increase of the Ly-6C hi subset ( Figure 1C ), whereas the Ly-6C lo population remained unchanged ( Figure 1D ). Consumption of a Western diet increased slightly the number of total circulating leukocytes in apoE -/mice (mean ± SEM, chow, 3.0 ± 0.5 × 10 6 cells/ml; Western diet, 3.9 ± 0.4 × 10 6 cells/ml; Figure 1E ). Blood smear counts showed that this increase arose primarily from monocytes (chow, 0.14 ± 0.03 × 10 6 cells/ml; Western diet, 0.94 ± 0.11 × 10 6 cells/ml), although granulocytes also increased (chow, 0.27 ± 0.03 × 10 6 cells/ml; Western diet, 0.96 ± 0.11 × 10 6 cells/ml) and lymphocytes decreased slightly (chow, 2.4 ± 0.6 × 10 6 cells/ml; Western diet, 2.0 ± 0.2 × 10 6 cells/ml). As expected (25, 26) , apoE -/mice on Western diet had increased serum cholesterol levels (479 ± 20 mg/dl) when compared with apoE -/mice on chow (286 ± 25 mg/dl). Macroscopic and histologic examination of aortas revealed fatty streaks and fibrous plaque lesions in the root and descending aorta of apoE -/mice regardless of diet. Lesions were identified along the entire aorta in older mice (i.e., mice that consumed Western diet for 50 weeks; data not shown). apoE -/mice consuming Western diet had 3-5 times more extended and widespread atherosclerotic lesions than did apoE -/mice on chow.
Figure 1
Hypercholesterolemia induces peripheral blood Ly-6C hi monocytosis. (A) Mononuclear cells from blood of apoE +/+ and apoE -/mice consuming either chow or Western diet were stained with anti-CD11b, -CD90, -B220, -CD49b, -NK1. apoE +/+ mice fed a Western diet had serum cholesterol levels of 227 ± 39 mg/dl, lower than those observed in apoE -/mice on Western diet but higher than those in apoE +/+ mice on chow (101 ± 10 mg/dl). apoE +/+ mice fed a Western diet did not show a significant increase in the number of circulating monocytes or Ly-6C hi monocytes (Figure 1 , B-D) and did not develop atherosclerotic lesions during the 25 weeks of diet consumption (data not shown).
apoE -/mice also had elevated numbers of CD11b + CD90 + B220 + CD49b + NK1.1 + Ly-6C + cells (chow, 3.0% ± 0.1% cells; Western diet, 3.8% ± 0.4% cells) than apoE +/+ mice (chow, 1.8% ± 0.3% cells; Western diet, 1.9% ± 0.2% cells). These cells were phenotypically distinct from monocytes and were not examined further.
Although the number of circulating monocytes increased dramatically in apoE -/mice fed Western diet, Ly-6C hi cells consistently expressed CD62 ligand (CD62L; also known as L-selectin) but not CD11c, while Ly-6C lo cells consistently expressed low levels of CD11c but not CD62L ( Figure 1F ), as previously reported for these monocyte subsets (21) . Morphologic analysis of flow-sorted cells also showed that cells of both subsets retained their size as well as their characteristic kidney-or horseshoe-shaped nuclei ( Figure 1G ).
Having determined that numbers of circulating monocytes increased in apoE -/mice on Western diet, we assessed the spatial and temporal course of monocytosis development by quantification of monocytes and their subsets in the bone marrow, peripheral blood, and spleen over 250 days of Western diet consumption ( Figure 2A ). Analysis included additional compartments because the bone marrow produces monocytes and the spleen may serve as a reservoir for monocytes in the periphery. Monocytosis developed progressively in all 3 compartments, and the blood and spleen showed predominant expansion of the Ly-6C hi subset. Statistical analysis matched the data to an exponential growth curve, permitting determination of doubling time for each tissue. The Ly-6C hi subset showed the lowest doubling times (95% confidence interval, 33 to 38 days in the blood), while, as expected, the Ly-6C lo monocyte subset had the highest doubling times (95% confidence interval, 145 to 256 days in the blood). Control experiments used blood from apoE +/+ and apoE -/mice during 250 days of chow consumption ( Figure 2B ). apoE +/+ mice on chow did not develop monocytosis, excluding the possibility that age drives the increase. apoE -/mice on chow showed moderate monocytosis. Statistical analysis matched the data to an exponential growth curve, though doubling times (e.g., 95% confidence interval, 63 to 86 days for Ly-6C hi monocytes in the blood) were 1.9-2.3 times longer than in apoE -/mice on Western diet. Thus, atherosclerosis and Ly-6C hi monocytosis arise concomitantly in apoE -/mice and show aggravation by Western diet.
Although we used the same criteria to define monocytes in the bone marrow and spleen as in blood (e.g., the CD11b hi CD90 lo B 220 lo CD49b lo NK1.1 lo Ly-6G lo phenotype), the preponderance of macrophages and dendritic cells in the spleen necessitated a secondary step to ensure that the cells were indeed monocytes. In the spleen, monocytes were further defined as F4/80 lo CD11c lo I-A blow. These cells had the same morphology as blood monocytes, whereas cells positive for F4/80, I-A b , and/or CD11c resembled macrophages or dendritic cells ( Figure 2C ). Because of the low number of monocytes in the blood, the spleen therefore furnished a rich source of mononuclear cells for further study.
Monocytosis results from increased survival, continued proliferation and impaired Ly-6C hi to Ly-6C lo conversion. Given that the progressive and peripheral monocytosis of the Ly-6C hi subset in apoE -/mice was most robust during consumption of Western diet, we next sought to determine whether a model modified lipoprotein, such as acetylated low-density lipoprotein (AcLDL), directly influences monocyte survival and/or proliferation. Initially, splenic Ly-6C hi and Ly-6C lo monocytes from apoE -/mice on Western diet were isolated and cultured for 24 hours in medium supplemented or not with 100 μg/ml AcLDL. The presence of AcLDL allowed Ly-6C hi cells to sur vive ( Figure 3A ) while retaining their monocytic Ly-6C hi F4/ 80 lo CD11c lo I-A b -low phenotype. Conversely, survival of Ly-6C lo cells did not change in the presence of AcLDL (data not shown). Because LDL can induce aortic endothelial cells to synthesize and secrete M-CSF (27), we assessed whether this factor can also influence the fate of monocytes in vitro. Supplementation of medium with M-CSF (50 μg/ml) for 24 hours partially fostered Ly-6C hi monocyte survival ( Figure 3A) .
These data suggest that LDL and/or its derivatives directly and indirectly promote the survival of Ly-6C hi monocytes. Nevertheless, the in vitro conditions used may not reproduce the in vivo environment in apoE -/mice on Western diet, since the number of Ly-6C hi monocytes did not increase in vitro. Therefore, we sought to compare directly the proliferation and survival of monocytes in vivo. apoE -/animals consuming either chow or Western diet received daily i.p. injections of BrdU for 3 days and were sacrificed 1 day later. Mononuclear cells were purified from the bone marrow, blood, and spleen, and monocytes were analyzed for apoptosis (annexin V) and proliferation (anti-BrdU mAb). The Western diet decreased the number of annexin V + cells within Ly-6C hi monocytes in the bone marrow and peripheral blood but not in the spleens of apoE -/mice ( Figure 3 , B and C). The Western diet concurrently increased the number of BrdU + cells within Ly-6C hi monocytes in peripheral blood and the spleen (Figure 3 , B and C).
Figure 3
Ly-6C hi monocytosis results from increased survival, continued proliferation, and impaired Ly-6C hi to Ly-6C lo monocyte conversion. (A) Ly-6C hi monocytes from the spleens of apoE -/mice were placed into culture with medium alone or medium supplemented with 100 μg/ml AcLDL or 50 μg/ml M-CSF. The percentage of cells alive 24 hours later was calculated based on the ratio of retrieved and input cell numbers. **P < 0.01, *P < 0. The vast majority of bone marrow monocytes incorporated BrdU regardless of diet, likely reflecting the continuous medullary production of these cells. These observations reflect the increased survival of dividing Ly-6C hi monocytes in apoE -/mice consuming Western diet, but may result from accelerated production in the bone marrow and/or from increased extramedullary proliferation. Interestingly, the higher levels of BrdU incorporation by Ly-6C hi monocytes in the spleen (mean fluorescence intensity, 528 ± 111) compared with the bone marrow (mean fluorescence intensity, 293 ± 63) indicate either continued proliferation in the periphery or selective emigration from the bone marrow of cells with longer proliferative histories.
Analysis of apoptosis and proliferation in apoE +/+ mice showed that Western diet increased survival and proliferation of monocytes in the spleen but not in the bone marrow or blood ( Figure 3 , B and C). Because apoE regulates apoptosis and cell cycle (28, 29) , it may participate in the differences observed between apoE +/+ and apoE -/mice.
To determine whether the Western diet also affects conversion of Ly-6C hi to Ly-6C lo monocytes, apoE -/mice on chow and Western diet received clodronate liposomes to deplete endogenous circulating monocytes (24) . Mice administered clodronate liposomes had a dramatically reduced number of Ly-6C lo F4/80 lo CD11c lo I-A b -low monocytes in blood (chow, 0.6 ± 0.2 × 10 4 versus 8.7 ± 4.6 × 10 4 cells/ml; Western diet, 1.1 ± 0.6 × 10 4 versus 9.6 ± 1.3 × 10 4 cells/ml) and spleen (chow, 2.4 ± 1.1 × 10 4 versus 32.5 ± 7.3 × 10 4 cells/ml; Western diet, 3.8 ± 0.9 × 10 4 versus 381.0 ± 84.2 × 10 4 cells/ml) 1 day after injection. Clodronate also strongly reduced the number of Ly-6C lo F4/80 hi CD11c hi I-A b -high macrophages/dendritic cells and moderately reduced the number of Ly-6C hi F4/80 lo CD11c lo I-A blow monocytes ( Figure 3D and data not shown) . The near absence of Ly-6C lo monocytes on day 1 allowed us to study their reemer-gence from the Ly-6C hi repertoire (Figure 3 , D and E). Five days after clodronate injection, Ly-6C lo monocytes had repopulated both blood and spleen in animals on chow but not in animals consuming Western diet (Figure 3 , D and E, and data not shown). Impaired Ly-6C hi to Ly-6C lo conversion in apoE -/mice consuming Western diet fostered Ly-6C hi monocytosis.
Ly-6C hi monocytes accumulate selectively in atherosclerotic lesions. Adoptively transferred EGFP + monocytes accumulate in atherosclerotic lesions (16) , but low numbers of EGFP + signals detected by immunohistochemistry prevent quantification of cell accumulation. Here we employed a recently established flow cytometry method (30) to phenotype single-cell suspensions of enzymedigested aortas and determined the in vivo relevance of Ly-6C hi monocytosis to atherosclerosis. Aortas from apoE +/+ and apoE -/animals on either chow or Western diet contained at least 2 distinct populations of cells expressing CD11b, identified in gate i as putative monocytes and in gate ii as putative macrophages (Figure 4, A Figure 4B ). Thus Western diet selectively increased Ly-6C hi monocyte accumulation in atherosclerotic aortas of apoE -/mice. As expected, aortas contained more macrophages and/or dendritic cells in apoE -/mice on Western diet (gate ii; 4.9 ± 1.7 × 10 4 cells) than on chow (1.1 ± 0.3 × 10 4 cells).
We counted relatively low numbers of Ly-6C hi and Ly-6C lo monocytes and macrophages/dendritic cells in the aortas of apoE +/+ mice regardless of diet (Western diet, 260 ± 10 Ly-6C hi monocytes, 310 ± 160 Ly-6C lo monocytes, 1.3 ± 0.5 × 10 4 macrophages/dendritic cells; chow, 220 ± 170 Ly-6C hi monocytes, 230 ± 120 Ly-6C lo monocytes, 1.2 ± 0.3 × 10 4 macrophages/dendritic cells; Figure 4B ).
The above cell numbers likely underestimate actual values, since the enzymatic digestion of aortic tissue required to obtain singlecell suspensions caused the death of many cells (90% ± 1% of events contributed to debris and dead cells, as defined by low forward scatter) that were excluded from the analysis. The actual difference in Ly-6C hi and Ly-6C lo monocyte numbers is overestimated if Ly-6C lo monocytes are more likely to die during isolation.
We performed immunohistochemical examination of aortic roots isolated from the apoE -/mice described above to evaluate the spatial distribution of Ly-6C hi cells in severe (fibrous plaque) and early (fatty streak) lesions ( Figure 4C and data not shown). Ly-6C colocalized with mononuclear-like cells on the intimal face of CD31 + endothelial cells but not with the bulk of Mac-3 + macrophage-rich areas in both types of lesions. These observations suggest that Ly-6C hi monocytes migrate to early and severe lesions and that differentiation into macrophages accompanies transmigration into the artery, although some Ly-6C hi monocytes may reside in the innermost layer of the intima. The relative number of Ly-6C hi cells compared with the number of Mac-3 + cells in these regions was 4.8 times higher in severe than in early lesions, suggesting that Ly-6C hi monocytes migrate more efficiently to severe lesions.
Ly-6C hi monocytes adhere preferentially to activated endothelium, accumulate in atherosclerotic plaques, and rapidly become lesional macrophages. Further examination followed the activity and fate of Ly-6C hi and Ly-6C lo monocytes isolated from either apoE -/or apoE +/+ mice on Western diet or chow. More than 70% of the cells remained alive in culture 24 hours after the isolation procedure (data not shown) and preserved monocytic markers (i.e., Ly-6C hi or Ly-6C lo , CD11b hi CD90 lo B220 lo CD49b lo NK1.1 lo Ly-6G lo , and F4/80 lo CD11c lo I-A b -low; Figure 5A ). We initially determined the capacity of monocyte subsets to adhere to TNF-α-activated murine cardiac endothelium under laminar flow conditions. Freshly isolated blood Ly-6C hi monocytes from apoE -/mice on either Western diet or chow adhered efficiently to the endothelium within minutes, while Ly-6C lo cells adhered significantly less well ( Figure 5B , white bars), as did naive lymphocytes (data not shown). Similar results were observed with monocytes isolated from apoE +/+ mice ( Figure 5B, black bars) . These results indicate that Ly-6C hi monocytes adhere preferentially to activated endothelium independent of diet or of the presence or absence of apoE. The relative proportion of circulating Ly-6C hi and Ly-6C lo monocyte subsets in apoE -/mice on Western diet suggests that greater than 95% of cells capable of binding to activated endothelium would belong to the Ly-6C hi subset ( Figure 5C ).
Further exploration used adoptive transfer of Ly-6C hi monocytes from CD45.2 apoE -/mice into congenic CD45.1 apoE -/recipients (both donor and recipient mice on Western diet for 25 weeks). Because peripheral blood contains few monocytes, splenic monocytes served as surrogates for circulating monocytes. After 24 hours, aortas from recipient mice were digested enzymatically, and single-cell suspensions were analyzed by flow cytometry. We counted 135 ± 4 donor cells in recipient aortas, of which approxi- mately 25% were Ly-6C hi and approximately 75% were Ly-6C lo ( Figure 5D ). Many donor cells showed enhanced expression of F4/80 and I-A b (Figure 5D ). Remarkably, the combined analysis of Ly-6C and F4/80 expression by donor cells revealed the existence of at least 3 distinct populations, Ly-6C hi F4/80 -, Ly-6C hi F4/80 + , and Ly-6C lo F4/80 + , resembling monocytes, monocytes in the process of differentiating into macrophages, and mature macrophages, respectively ( Figure 5E ). These phenotypic relationships are comparable to those observed among endogenous populations ( Figure 4A ). In contrast, donor cells retrieved from the spleens of the same mice remained phenotypically unchanged ( Figure 5D ). These results demonstrate recruitment of Ly-6C hi monocytes to atherosclerotic aortas, followed by local and rapid (<24 hours) differentiation into macrophages. Combined with the restricted localization of Ly-6C hi monocytes to the luminal face of the endothelium, these data suggest that differentiation into macrophages accompanies transmigration and also support the notion that aortic monocyte detection did not result from contamination of circulating cells.
To determine the relative capacity of Ly-6C hi and Ly-6C lo monocytes to migrate to atherosclerotic aortas and to determine whether accumulation of Ly-6C hi cells mapped to lesions, we labeled equal numbers of splenic Ly-6C hi and Ly-6C lo monocytes from apoE -/mice on Western diet with [ 111 In]oxine and injected them separately into apoE -/mice on Western diet. After 24 hours, we excised the aortas and calculated the percent injected dose per gram of tissue, which revealed that Ly-6C hi cells preferentially accumulated in aortas ( Figure 5F ). Autoradiography showed discrete regions of activity only in recipients of Ly-6C hi cells ( Figure 5G ). The lack of such regions in animals receiving Ly-6C lo cells suggests that the signals detected in these mice corresponded to background activity. The radioactive signal observed for Ly-6C hi cells always mapped directly to areas containing lesions as determined microscopically, but not all lesions showed focal areas of radioactivity (data not shown). The relative proportion of circulating Ly-6C hi and Ly-6C lo monocyte subsets in apoE -/mice on Western diet suggests that greater than 90% of cells accumulating in atherosclerotic lesions originate from the Ly-6C hi subset ( Figure 5H ). Taken together, these results suggest that circulating Ly-6C hi monocytes are direct precursors of lesional macrophages.
Expression of MCP-1 by a subset of cells in atherosclerotic lesions suggests active recruitment of monocytes to developing lesions in vivo (31, 32) , and mice lacking MCP-1 or C-C motif chemokine receptor 2 (CCR2) show reduced atherosclerosis (33) (34) (35) . Thus monocyte recruitment into lesions may require CCR2 expression, a feature of the Ly-6C hi subtype (19) . Testing this hypothesis involved the adoptive transfer of Ly-6C hi monocytes from bone marrow of CCR2 -/mice into peripheral blood of atherosclerotic (CCR2 +/+ ) apoE -/mice. We counted only 14 ± 2 donor cells in recipient aortas, suggesting that Ly-6C hi monocyte accumulation in lesions does indeed depend on CCR2.
Statin administration attenuates Ly-6C hi monocytosis. Having shown that lesional macrophages were derived from circulating Ly-6C hi monocytes in atherosclerosis, we sought to determine whether reduction of Ly-6C hi monocytosis attenuates disease. Repeated administration of anti-Ly-6C mAb could theoretically control Ly-6C hi monocytosis. This approach is impractical, given the chronic nature of atherogenesis, and may not keep the size of the Ly-6C hi monocyte population at homeostatic levels, but rather trigger transient cell depletion upon each mAb injection. In contrast, since inhibitors of hydroxymethylglutaryl coenzyme A reductase (statins) decrease cholesterol levels, exert antiinflammatory effects, and attenuate atherosclerosis (36, 37) , we sought to determine whether concurrent treatment of apoE -/mice on Western diet with statin also modulates the extent of monocytosis. Mice analyzed after 25 weeks of atorvastatin treatment had significantly attenuated serum cholesterol levels when compared with age-matched littermates on Western diet ( Figure 6A ). The statin treatment also reduced monocytosis ( Figure 6B ). Specifically, the numbers of Ly-6C hi monocytes declined significantly in the spleen and peripheral blood (although they remained higher than in apoE -/mice on chow), whereas the numbers of Ly-6C hi monocytes in the bone marrow fell to levels found in apoE -/mice on chow ( Figure 6B ). The statin treatment also reduced the numbers of the Ly-6C lo monocytes in the spleen. Antiinflammatory effects of statins beyond LDL lowering could also participate in the attenuation of Ly-6C hi cell numbers.
Blood Ly-6C hi monocyte counts positively associated with serum cholesterol levels in apoE +/+ (data not shown) and apoE -/mice ( Figure 6C ). Furthermore, correlation between Ly-6C hi numbers from statin-treated apoE -/mice conformed to a linear axis between chow-and Western diet-fed animals. Such correlative analysis did not apply for blood Ly-6C lo monocytes, since Ly-6C lo cell counts were similar for all serum cholesterol concentrations.
Discussion
This study shows that hypercholesterolemia in apoE -/mice induced the progressive and selective expansion of Ly-6C hi monocytes, a phenomenon we have termed HAM. Ly-6C hi monocytes participate in atherosclerosis because they preferentially adhered to activated endothelium, accumulated in lesions, and locally differentiated into macrophages, the predominant leukocytes during plaque inflammation and development. Although we did not describe a role for Ly-6C lo cells in atherosclerosis, future studies may determine whether this subset, as a possible precursor of dendritic cells (38) , influences the adaptive arm of the immune system, particularly with respect to antigen presentation and lymphocyte activation, processes known to occur in atherosclerosis (1) .
HAM results from continued bone marrow production of Ly-6C hi monocytes, increased survival of these cells in the periphery, and impaired conversion to the Ly-6C lo subset. Monocytosis was characterized by a doubling of the Ly-6C hi population every month in peripheral blood, generating up to 1.4 × 10 6 cells/ml after 250 days of diet; although the rate of Ly-6C hi monocytosis was slightly slower in the spleen (doubling time of around 2 months), this organ served as a much larger reservoir of Ly-6C hi monocytes, reaching approximately 2 × 10 7 cells after 250 days of diet. Moreover, since the number of Ly-6C hi monocytes continuously increased during the 250 days of the study, monocyte expansion would likely have persisted beyond this point.
We suggest that Ly-6C hi monocytosis requires elevated concentrations of cholesterol or lipid derivatives, since (a) monocytosis occurred in mice fed Western diet, (b) the presence of a choles-terol-lowering drug of the statin class at least partially controlled monocytosis in vivo, and (c) the addition of LDL for 24 hours to purified Ly-6C hi monocytes in vitro allowed for their increased survival without promoting differentiation into macrophages. These findings demonstrate that augmented serum cholesterol levels, in addition to promoting lipid deposition in lesions (39) and inducing M-CSF production for local monocyte maturation into macrophages (40, 41) , also trigger the expansion of circulating monocytes. These data suggest that a cholesterol-rich diet promotes murine atherogenesis, at least in part through the development of monocytosis. Molecules such as M-CSF, GM-CSF, PI3K, and NF-κB are induced by constituents of modified LDL and mediate the expansion and maturation of macrophages (42, 43) . It will be of interest to determine whether similar pathways also elicit Ly-6C hi monocytosis and why circulating Ly-6C lo monocytes appear less sensitive to the same stimuli.
Following the fate of adoptively transferred, purified monocyte subsets revealed that lesional macrophages derived predominantly from circulating Ly-6C hi monocytes, pointing to an active role in this process for the membrane-bound, glycosylphosphatidylinositol-linked protein Ly-6C (44) (45) (46) . Future studies will show whether Ly-6C serves only as a marker for or also contributes functionally to inflammatory monocytes, whether Ly-6C characterizes inflammatory cells capable of tissue transmigration, and whether therapeutic targeting of Ly-6C, or a human equivalent, contains monocytosis and consequently reduces atherosclerosis.
The observation that Ly-6C hi cells trafficked differentially to lesions supports the concept of heterogeneity of atheromata (47, 48) and suggests that these cells migrate preferentially to lesions of high inflammatory activity. Interestingly, fatty streaks harbored few Ly-6C hi monocytes, indicating low monocyte accumulation at this stage. Expression of CD62L also suggests a role for Ly-6C hi monocytes in antigen presentation in secondary lymphoid organs and participation in adaptive immunity.
Activated macrophages, operationally categorized as M1 cells (classically activated macrophages), are induced by IFN-γ and generate inflammation, while M2 cells (alternatively activated macrophages) generated in response to IL-4 or IL-13 can exhibit immunoregulatory function (49, 50) . Ly-6C hi monocytes selectively populate sites of experimentally induced inflammation and can locally differentiate into M1 cells. However, whether the cytokine milieu recruits and/or activates specific monocyte subsets, or indiscriminately polarizes already accumulated subsets for particular macrophage function will require further study.
Clinical data have shown a positive correlation between white blood cell count and acute myocardial infarction (5) (6) (7) . More recently, a study showed that monocytosis is an independent risk factor for coronary artery disease (51) . Here we propose that monocytosis is an etiologic constituent of experimental atherogenesis. Future research will determine whether humans with elevated serum cholesterol and/or C-reactive protein exhibit CD14 hi CD16monocytosis, and whether this variable relates to atheroma burden or complications. Overall, our present results indicate a striking and dynamic alteration of the monocyte repertoire during experimental atherogenesis, recognize circulating Ly-6C hi monocytes as key mediators of chronic inflammation, and suggest what we believe to be novel mechanistic hypotheses regarding the interface of innate immunity and atherosclerosis that will require future testing experimentally and in humans. decay, excretion, and tail radioactivity from occasional subtle extravasations. Digital autoradiography was used with high-sensitivity screens and 50 μm readout (Phosphorimager Screen; Molecular Dynamics; GE HealthCare) for visualization of the spatial distribution of isotopelabeled cells throughout the aorta. Accumulation was normalized to relative contribution of Ly-6C hi and Ly-6C lo monocytes in blood of apoE -/mice fed Western diet.
Serum cholesterol measurement. At the time of sacrifice, blood was obtained by retroorbital bleeding. Serum was obtained by centrifugation at 16 g for 15 minutes at 37°C. Serum cholesterol levels were measured using a cholesterol kit (Hemagen Diagnostics Inc.).
Statistics. Data are expressed as mean ± SEM. Statistical tests included unpaired, 2-tailed Student's t test using Welch's correction for unequal variances and 1-way ANOVA with Tukey's multiple comparison test. Statistical analyses were done using Prism. A P value of 0.05 or less was considered to be significant.
